Evidence 2011 Speakers
We are delighted to announce the participation of these international healthcare leaders at Evidence 2011.

Prior to his current role Gary was the director of commissioning. He has over 25 years’ experience in the NHS and DH. His previous roles included head of primary care in the DH, chief executive of an NHS trust and deputy chief executive of a community and mental health trust.
As director of commissioning, Gary was the architect of world-class commissioning. This is seen as a leading edge development and the significant 'co-production' with the NHS to create WCC has set the standard for future policy development between DH and the NHS.
Gary Belfield is the Director of Commissioning in the DH Commissioning and System Management Directorate. Gary has over 20 years' experience in the NHS and DH. His previous roles have included Head of Primary Care in the DH, Chief Executive of a NHS Trust and the deputy CE of a Community & Mental Health NHS Trust.
In 5 years at the DH Gary has led the team who created the models for Practice Based Commissioning (PBC), Long Term Conditions (LTC) and new PECs. In his current role, Gary is responsible for developing a vision for World Class Commissioning (WCC) including identifying the key strategic competencies. His team are designing the earned autonomy model and identifying the incentives to underpin this. The creation of a development is the third strand of WCC with the overall aim of adding years to life and life to years for the population. This major piece of work will help support PCTs and professionalise commissioning. PBC continues to be a key policy in Gary’s portfolio and in August 2007 he took on responsibility to implement the framework for procuring external support for commissioners (FESC). Both PBC and FESC will play a key role in developing WCC.

Patrick M. Bossuyt, PhD is the professor of Clinical Epidemiology at the University of Amsterdam and chaired the department of Clinical Epidemiology, Biostatistics and Bioinformatics at that University for ten years. His scientific work is built on two tracks. Dr Bossuyt collaborates with clinical departments in the Academic Medical Center of the University of Amsterdam in designing and running clinical trials and in translating the results of these studies into guidelines and policy recommendations. Patrick Bossuyt also leads the Biomarker and Test Evaluation Program, to develop the methodology for evaluating medical tests and biomarkers. He spearheaded the STARD initiative for the improved reporting of diagnostic test accuracy studies. Dr Bossuyt has authored and co-authored more than 500 publications in peer reviewed journals and serves on the editorial board of a number of these.

Jon specialises in understanding and meeting the information needs of clinicians. He works extensively in the world of clinical question answering and has run numerous services. He and his various teams have answered over 10,000 clinical questions. As a result of his work he created and still runs the clinical search engine the TRIP Database (www.tripdatabase.com). The TRIP Database has been running for over ten years and is used worldwide. In 2010 it surpassed 50 million searches since its launch. As well as working on the TRIP Database he works for Public Health Wales also involved in clinical knowledge support.
His main current areas of interest include the limitations of search, the personalisation of information (including for the developing world), the use of social media (twitter, blogs) and meeting unknown information needs.

Juan is a Cardiologist and Clinical Epidemiologist. In 1996 he was a visiting fellow at the Institute of Health Sciences in Oxford and upon his returned to Spain founded CASP Spain where he remains its current director. This organization teaches skills in searching for and critically appraising evidence to inform health care decisions. CASP Spain undertakes outreach teaching and has run over 500 workshops throughout the Spanish National Health System involving more than 6,000 practitioners. As part of the CASP International Network, Juan has collaborated in launching and developing a large number of “CASP cascades” in other countries (Peru, Mexico, Poland etc.)
Juan is Senior Fellow of the Oxford Centre for Evidence Based Medicine where he has led the Spanish speaking groups in the “How to teach EBM” course since 1997, he is also involved in the Oxford MSc in EBHC. In addition he is a member of several Cochrane groups, leading the Cochrane review about the effect of Oxygen in Acute Myocardial Infarction and collaborating on other Cochrane reviews.
He still devotes part of his time to caring for patients at Alicante General University Hospital where he was previously Director of the Research Unit and co-ordinator of the “PhD programme in Clinical Research”.

Dr. Tammy Clifford is the Chief Scientist at the Canadian Agency for Drugs and Technologies in Health (CADTH). Her current responsibilities include accountability for the overall quality of CADTH’s work, ensuring alignment with international best practices in HTA methodology, and increasing HTA capacity via education, training and outreach. She joined CADTH in 2005, and continues to hold faculty appointments in Pediatrics and in Epidemiology and Community Medicine at the University of Ottawa.
Dr Clifford received her PhD in Epidemiology and Biostatistics from the University of Western Ontario and both her BSc and MSc(A) from McGill University. Her particular fields of interest relate to the methodological underpinnings of health technology assessments and rapid reviews as well as issues related to updating and the editorial peer review process. Dr. Clifford is actively involved with a number of organizations, including the International Network of Agencies for Health Technology Assessment (INAHTA), and Health Technology Assessment International (HTAi).

Deborah Cohen is investigations editor of the BMJ, which she joined after studying medicine at both Manchester University and Universite de Rennes. Whilst at university she intercalated in medical journalism, edited her university publication and worked on a newspaper in Ghana covering health and human rights. Deborah has reported from a variety of places including the West Bank, Kenya and Ethiopia.
As investigations editor of the BMJ, much of her work has focused on drug and medical device regulation, access to clinical data and conflicts of interest. She has collaborated on documentaries with the BBC, Channel 4 News and Dispatches, and Al-Jazeera, as well has having working jointly with the Bureau of Investigative Journalism.

Sally has a nursing and public health background. As director of Crowe Associates Ltd, which provides consultancy, training and project management for patient and public involvement in health, she regularly facilitates workshops and consultation events in health and social care research, and services development. Teaching critical appraisal and understanding evidence skills continues to be a passion. She has recently published a BMJ Wiley Blackwell Patient and Public Involvement Toolkit.
She chairs the James Lind Alliance Monitoring and Implementation Group (www.lindalliance.org), a national coalition that aims to tackle treatment uncertainties in health care. This is primarily achieved through partnerships of patient and clinician groups, and Sally is currently working with partnerships for eczema, type 1 diabetes, pressure ulcers and pre term birth. The James Lind Alliance is funded by the Department of Health and the Medical Research Council.

Dr Philippe Duclos is a native of France where he trained as a DVM. His interest in infectious microbiology and epidemiology lead him to also complete a PhD (Claude Bernard University, 1988). From 1981 through 1986 he served as Associate Professor in the Department of Infectious Diseases and Zoonotic Diseases at the Veterinary School in Lyon. In 1986, he moved to the USA and served as Epidemic Intelligence Service Officer. He spent 3 years studying ways to mitigate the impact of man made and natural disasters at the Centers for Disease Control and Prevention, Atlanta. In 1989, he moved to Ottawa, Canada to develop a vaccine post-marketing surveillance program for the federal government at the Laboratory Centre for Disease Control and in 1991 became the Chief of the Division of Immunization, position which he held until August 1998. Involved in the various aspects of the Canadian Immunization program, he was key to the establishment of fairly unique surveillance and investigation tools such as the active paediatric surveillance network based in paediatric hospitals (IMPACT) and the Canadian Paediatric Surveillance Program. He also served as Associate Professor, Department of Community Medicine, Faculty of Medicine, University of Montreal and as adjunct professor, Department of Epidemiology and Community Medicine, Faculty of Medicine, University of Ottawa of which he is still a member of the school of graduate studies. In 1993 he gained the Canadian citizenship.
Since September 1998, Dr. Duclos was recruited by the World Health Organization in Geneva where he works within the Department of Immunization, Vaccines and Biologicals. After working in the Vaccine Assessment and Monitoring team and serving as project leader for the Immunization Safety Priority Project and focusing mostly on vaccine safety monitoring and investigation of vaccine safety issue of global importance, he now serves as Senior Health Adviser in the Director's office and oversees the immunization policy unit which includes serving as Executive secretary for the Strategic Advisory Group of Experts and overseeing the development of vaccine position papers.
He is the author or co-author of over 200 publications and of numerous invited presentations at international conferences.

Professor Ernst qualified as a physician in Munich, Germany in 1976. In 1978 he completed his MD thesis and in 1985 his PhD. He was appointed Professor in Physical Medicine and Rehabilitation (PMR) at Hannover Medical School (Germany) in 1989. Eighteen months later he accepted the post of Head of the PMR Department at the University of Vienna (Austria). He came to the University of Exeter (UK) Postgraduate Medical School in October 1993, establishing the worldwide first Chair in Complementary Medicine. In 1996 he founded the Department of Complementary Medicine at this University’s Postgraduate Medical School and in 2002 his unit became part of the new Peninsula Medical School, Universities of Exeter and Plymouth.
Professor Ernst has ‘hands on’ experience of a range of complementary therapies, including herbal medicine, homoeopathy, massage therapy, spinal manipulation, acupuncture and autogenic training. He has contributed extensively to medical literature in several areas: Haemorheology, Angiology, PMR and Complementary/Alternative Medicine (CAM). In total he has published more than 1000 papers (>600 in CAM) in the peer -reviewed medical literature, about 500 primary research contributions and over 40 books (translated into well over a dozen languages). He is founder/ Editor-in-Chief of two medical journals (FACT [‘Focus on Alternative and Complementary Therapies’] and ‘Perfusion’) and is on the editorial board of more than 20 medical journals. He is a regular reviewer for many publications including the Lancet, BMJ, JAMA and the Archives of Internal Medicine.
His work has been awarded with 13 scientific prizes/awards and he was a Visiting Professor at Roy Coll Surgeons, Canada (1999) and at the University of Southern California, Los Angeles (2005). He served as an external examiner for the Universities of Berlin, Bombay, Derby, Dublin, Hannover, London, Manchester Metropolitan, Munich, Oxford, Sydney, Ulster, Zürich and others. He has supervised ~50 MD or PhD theses and given about four hundred invited international lectures. He served on the ‘Medicines Commission’ of the British ‘Medicines and Healthcare Products Regulatory Agency’ (1994 – 2005) and on the ‘Scientific Committee on Herbal Medicinal Products’ of the ‘Irish Medicines Board’. He is patron of two British CAM organisations and honorary member of several dozen others. He has served as an expert witness to the UK High Court and the British General Medical Council.
In 1999 he took British nationality. In 2000 he was granted an entry in the “Who’s Who”. He writes or wrote regular columns for ‘The Guardian’ (2003-5), The Chemist Druggist, The Pharmaceutical Journal, Independent Nurse Magazine, Münch Wed Wschr and Stern (Gesund Leben), SonntagZeitung (Switzerland) and has his own blog (www.pulsetoday.co.uk/rss.asp?navcode=969).

I have worked for more than 40 years in the NHS and am still working as a part time Respiratory Physician at Manchester Royal Infirmary. I have worked at a DGH, in Medical Education and more recently in a Teaching Hospital. I retired a little early after a serious illness but finding myself completely cured, my wife and I fulfilled a lifelong ambition by working as VSO volunteers in Uganda.
Financially this worked out well as we could live on my pension but our work in Uganda was very special, making many new friends and coming home really having felt we had made a difference. The work I did I will describe in my presentation.
The work was very much a team effort and it is ongoing but it gave us the opportunity to investigate whether a Tuberculosis culture test was cheap and effective and then use it, to help the many sufferers of this disease in Uganda.

Mark Gibson is the Director of the Center for Evidence-based Policy at the Oregon Health and Science University, and a program officer for the Milbank Memorial Fund. In these roles he works extensively with state policy makers to identify and obtain research evidence needed to inform their policy deliberations. Gibson has played a key role in developing two multi-state collaborations, the Drug Effectiveness Review Project (DERP) and the Medicaid Evidence-based Decisions (MED) project.
Mr. Gibson served as Chief of Staff to Oregon Senate President John Kitzhaber M.D from 1985-1993. In this role, Gibson participated directly in the drafting and passage of the groundbreaking Oregon Health Plan.
From 1995 through January of 2003, he served as Policy Advisor for Health, Human Services, and Labor to Governor John Kitzhaber of Oregon. He led Oregon’s numerous health initiatives from Workers’ Compensation Reform, to creation of the Oregon Children’s Health Insurance Program and an expansion of the Oregon Health Plan. Gibson led the effort to enact Oregon’s answer to runaway drug costs in its Medicaid program. This approach uses systematic reviews of global drug effectiveness research to guide the creation of a preferred drug list that is both clinically sound and economical.

Trish joined Barts and the London Medical School in April 2010 to set up the Healthcare Innovation and Policy Unit within the Centre for Health Sciences. She previously worked for many years at UCL. Trish is a general practitioner in north London. She gained her first degree in Social and Political Sciences from Cambridge University in 1980 and qualified in Medicine from Oxford University in 1983. Her research interests lie at the interface between sociology and medicine. She uses innovative interdisciplinary approaches, drawing on narrative, ethnographic and participatory methods, to explore complex, policy-related issues in contemporary healthcare.
Trish is the author of 120 peer-reviewed journal articles and 8 textbooks. Her many awards and prizes include Order of the British Empire for Services to Medicine, National Institute for Health Research Senior Investigator Award, Royal College of General Practitioners Research Paper of the Year Award (twice) and European Health Management Association Baxter Prize for Outstanding Contribution to Research in Healthcare Management (twice). She is a member of the Medical Research Council Committee on Good Research Practice, World Health Organisation Expert Advisory Panels on Clinical Practice Guidelines and Research Methods and Ethics and RAND/IHI International Working Group on Patient Safety.

Phil Hammond is a GP, writer, broadcaster and possibly the only comedian to appear at a public inquiry. He is Private Eye’s medical correspondent and broke the story of the Bristol heart scandal in 1992, which lead to the largest public inquiry in British history 7 years later. In 2009, he broke allegations of serious errors in pathology reporting in Bristol, which lead to an inquiry in just 7 days. He has survived Ruby Wax, Have I Got News For You (7 times), The News Quiz, The Now Show, and being reported to the General Medical Council by William Hague’s Press Secretary. He was also the only doctor to appear for the prosecution on Channel 4’s Doctors on Trial.
Brought up in Australia before moving to Marlborough, Hammond qualified as a doctor in 1987 from Girton College, Cambridge University and St Thomas’ Hospital Medical School. He became a GP in 1991 but first came into the public spotlight writing a column for The Independent and as half of Struck Off and Die, with Tony Gardner. They had five sell-out shows at the Edinburgh Fringe, were twice selected for the Perrier Pick of the Fringe and won Writers’ Guild and Silver Sony Awards when the show transformed into a Radio 4 series. In 2002, Phil fronted 28 Minutes to Save the NHS on Radio 4, which he extended to a sell out Edinburgh Fringe Show, 59 Minutes to Save the NHS and further extended to a highly successful 60-date UK tour 89 Minutes to Save the NHS.
Hammond still works part time as a GP and lecturer, but is better known for his TV work. He presented five series of Trust Me, I’m a Doctor on BBC 2, exposing wide variations in care across the NHS and co-wrote the sitcom, Doctors and Nurses, broadcast on BBC 1 in 2004. A GP-based sitcom, Polyoaks, has just been commissioned by Radio 4. He presents The Music Group for Radio 4 and is the author of three best-selling books: Medicine Balls (an NHS satire), Trust Me I’m Still a Doctor (20 years of whistle-blowing in Private Eye) and his latest book, a pleasure manual entitled Sex, Sleep or Scrabble? is based his experiences working in Sexual health. This is also the inspiration behind his latest live show Dr. Phil’s Rude Health Show, which goes on tour from April 2010. A DVD of Dr Phil’s Rude Health Show will also be released in 2010.

Tom “joined” the Cochrane Collaboration after reading an editorial by Iain Chalmers (whom Tom regards at the John Charles of medicine). Tom has since co-authored twenty-five reviews, and has struggled to encourage the assessment of the effects of vaccines. Tom is one of the editors of the Cochrane ARI Group, a member of four other review groups, two methods groups and the co-ordinator of the Cochrane Vaccines Field. His main research interests are the application of systematic reviewing methods to studies of vaccines and antivirals of different designs (such as trials, economic evaluations and epidemiological studies) and peer review.
Tom was a visiting fellow at the UK Cochrane Centre in Oxford between 1999 and 2001 and coordinated the Italian National guidelines programme during 2001-2003.
While pursuing his research activity, Tom has published over two hundred papers and co-authored five books. Tom has co-reviewed the evidence of the effects of editorial and grant application peer review and the effects of interventions to prevent and treat the common cold (funded by a British Medical Association HC Roscoe Fellowship) and the evidence of safety of MMR, DTP, aluminium-containing DTP and Hepatitis B vaccines as part of European Union and World Health Organisation funded projects. At present Tom is updating and re-appraising the content of the acute respiratory infections group reviews is co-author. The slide show in this JC is one of the first fruits of this activity.
Tom is currently reviewing the effects of influenza vaccines and antivirals for the Cochrane collaboration and is a founder member of the Brighton Collaboration.

Professor Mike Kelly is Director of the Centre of Public Health Excellence at NICE where he leads on the development of public health guidance. He is a public health practitioner, researcher and academic. He originally graduated in Social Science from the University of York, holds a Masters degree in Sociology from the University of Leicester, and undertook his PhD in the Department of Psychiatry in the University of Dundee. Before joining NICE he was Director of Evidence and Guidance at the Health Development Agency. Professor Kelly has previously held academic posts at the Universities of Leicester, Dundee, Glasgow, Greenwich and Abertay. He is now Honorary Professor in the Department of Public Health and Policy at the London School of Hygiene and Tropical Medicine, Honorary Professor in Community Based Medicine, in the Faculty of Medical and Human Sciences, the University of Manchester, Visiting Professor in the School of Health and Related Research, University of Sheffield, Honorary Professor of Public Health, University of Salford, an Associate in the Behaviour and Health Policy Research Unit, Institute of Public Health, University of Cambridge and Honorary Visiting Professor in the Department of Public Health, Primary Care and Food Policy in the School of Community and Health Sciences, City University, London. He is a Fellow of the Faculty of Public Health and an Honorary Fellow of the Royal College of Physicians.
Professor Kelly is a medical sociologist with research interests in evidence based approaches to health improvement, methodological problems in public health research, evidence synthesis, coronary heart disease prevention, chronic illness, disability, physical activity, health inequalities, social identity and community involvement in health promotion. From 2005-8 he was the co leader of the Measurement and Evidence Knowledge Network of World Health Organisation’s Commission on the Social Determinants of Health. He has published more than two hundred papers in medical, social scientific and public health journals and is author/ editor of seven books. In 2010 he was awarded the Alwyn Smith Prize of the Faculty of Public Health for his work on cardiovascular disease and alcohol misuse prevention.

Sir Bruce Keogh has been Medical Director of the NHS in England since 2007. He is responsible for clinical policy and strategy in the Department of Health and oversees the work programmes of the National Patient Safety Agency (NPSA), Medical Education England and until recently, the National Institute of Clinical and Healthcare Excellence (NICE). He has served as a Commissioner on the Commission for Health Improvement (CHI) and the Healthcare Commission. He was previously Professor of Cardiac Surgery at University College London and Director of Surgery at the Heart Hospital. He was knighted for services to medicine in 2003.

Steven is trained as a General Practitioner and Public Health Consultant and currently works as a GP in a large practice in Hertfordshire and also an Associate Medical Director for NHS East of England.
Steven has recently been appointed as the National Clinical Lead for Shared Decision Making as part of the National Right Care QIPP workstream (Right Care for Patients). He co-chairs the Long Term Conditions Clinical Programme Board in NHS East of England. He is also a National Clinical Advisor to the Department of Health (Elective Care and Diagnostics).
He also works as a freelance health care consultant, especially in relation to pathway redesign and commissioning.
Steven has commissioned a web solution (Pathways for Health) for the development of local commissioning care pathways, based upon the template he, and a colleague, developed for the DH 18 Week Team. Pathways for Health has been used for the development of 50 pathways for the 18 Week Programme, as well as many other national, regional and local pathways for a range of health and patient charitable organisations.
Steven qualified from the Royal Free Hospital Medical School in 1991 and trained initially in hospital medicine, gaining his Membership of the Royal College of Physicians. He then went on to train in general practice in Hertfordshire and subsequently specialist public health training in London and Hertfordshire, gaining a Masters in Public Health at the London School of Hygiene and Tropical Medicine and completing his public health specialist training.
Steven’s particular medical interests include care pathways, demand management, long term conditions, patient empowerment, patient leadership and Shared Decision Making.
He lives with his wife and three young children in St Albans, Hertfordshire.

Stefan Lange completed his medical studies at the Heinrich-Heine-University in Düsseldorf in
1989 and received his MD in 1994. From 1989-1993 he was initially in practical training at the
Ferdinand-Sauerbruch-Clinic in Wuppertal, then assumed the position of intern/resident
physician. In 1993 he joined the department of medical computer sciences, biometrics and
epidemiology at the Ruhr-University in Bochum and was appointed to the position of an
assistant professor in 1995.
He was awarded the certificate of Biometrics in Medicine with the
title of “Qualified Statistician” by the German Association for Medical Computer Sciences,
Biometry and Epidemiology (GMDS) in 1999. In 2003 he received his PhD (second thesis) at the
Ruhr University and received the venia legendi (right to teach) in Medical Biometry and Clinical
Epidemiology.
He joined the Institute for Quality and Efficiency in Health Care in 2004, and has held the
position of Deputy Director of the institute since 2005. Having headed the department of Non-
Medical Interventions until 2007, he has devoted himself solely to the responsibilities of his
position as Deputy Director since 2008.

Trained in Emergency Medicine in the North West and appointed Consultant at MRI and FCEM in 1993. Kevin has Published widely on the practice of Emergency Medicine, both books (Advanced Paediatric Life Support, Major Incident Medical Management and Support, Emergency Triage) and academic papers. As well as consulting at MRI and Booth Hall is also Executive Medical Director of the North West Ambulance Service, Civilian Consultant Advisor to the British Army and Head of the North Western School of Emergency Medicine.
Kevin is the founder of Best Bets developed by the Emergency Department at Manchester Royal Infirmary. They arose out of a desire to provide brief reviews of the best evidence about specific topics, in a way that met the specific needs of Emergency Medicine. The CATs used by Sackett were seen as a starting point for developing a method of EBM topic review tailored for Emergency Medicine. BETs have been used as a central part of the department's critical appraisal journal club, for staff and students, and have formed a focus point for an intensive training in critical appraisal for medical students.

Paul's career is focused on furthering the understanding of what interventions are actually effective in tackling complex psycho-social problems. This requires integrating the best from a wide range of different methodologies (systematic reviews, randomised controlled trials, etc), many of which have not previously been widely applied in the social sciences despite being at the top of the evidence based hierarchy.
Paul's work encompasses a wide variety of different psycho-social problems affecting different population groups, from learning disabled children, through groups at risk of HIV to the demented elderly with sleep problems. Although all of these different populations and problems present unique methodological challenges, there are nonetheless many common elements to developing successful interventions that will then translate into effective policy and practice.
It is the challenge of pulling together these common elements that continues to drive his work. The multifactorial nature of almost all complex psycho-social problems requires a multidisciplinary approach to their solution. The diversity of the problems that his research group have been working on has been a positive strength, because it has allowed them to develop novel methodological approaches by adapting and combining the best strategies from many different fields.

Dr Yannis Pitsiladis is a Reader in Exercise Physiology at the Institute of Cardiovascular & Medical Sciences in the College of Medicine, Veterinary & Life Sciences at the University of Glasgow and founding member of the “International Centre for East African Running Science” (ICEARS) set up to investigate the determinants of the phenomenal success of east African distance runners in international athletics. Recent projects also include the study of elite sprinters from Jamaica and the USA and the study of world class swimmers (e.g., why are there very few black swimmers?). He is a Visiting Professor in Medical Physiology at Moi University (Eldoret, Kenya) and Addis Ababa University (Addis Ababa, Ethiopia). He is a member of the Scientific Commission of the International Sports Medicine Federation (FIMS) and a member of the World Anti-Doping Agency (WADA) List Expert Group; the WADA Group in charge of establishing the Prohibited List annually. He is also a Fellow of the American College of Sports Medicine (ACSM).

David Spiegelhalter has been Winton Professor of the Public Understanding of Risk at the University of Cambridge since October 2007, which he combines with being a Senior Scientist in the MRC Biostatistics Unit. His background is in medical statistics, including clinical trials and drug safety, and he has consulted and taught in a number of pharmaceutical companies. He also collaborates on developing methods for health technology assessment applicable to organisations such as NICE. His interest in performance monitoring led to his being asked to head the statistical team in the Bristol Royal Infirmary Inquiry, and he also gave evidence to the Shipman Inquiry. He acts as a statistical consultant to the Care Quality Commission, advising on performance rating, monitoring targets, risk-based hospital inspection, and surveillance methods.
In his post he leads a small team which is attempting to improve the way in which the quantitative aspects of risk and uncertainty are discussed in society.
He was elected FRS in 2005 and awarded an OBE in 2006 for services to medical statistics.

Dr Kristina Staley is a Co-Director of TwoCan Associates, (www.twocanassociates.co.uk) a small company which specialises in researching, promoting and supporting patient and public involvement in health and social care.
After gaining her PhD from Cambridge University, and working as a post-doctoral fellow in the USA, she moved into health and science policy working at the King's Fund and Sussex University's Science Policy Research Unit. For many years her work focused on involving the public in research and development in order to inform policy and practice in health and social care. She is the author of INVOLVE’s recent report Exploring Impact: Public Involvement in NHS, public health and social care research.

Michael has spent the last five years working in anti-doping having joined UK Sport in 2006 before moving over to UK Anti-Doping when it was formed in December 2009. In March 2010 Michael was appointed as the Head of Science and Medicine.
In this time he has led on a number of organisation initiatives including a full steroid profiling programme, a blood profiling programme, the nutritional supplements risk management review resulting in HFL’s Informed-Sport and establishing a research programme within UK Anti-Doping, the current highlight of which is the ongoing support to the GH-2004 research team in establishing a new Growth Hormone test. Michael’s team lead the UK Anti-Doping consultation process on the World Anti-Doping Prohibited List on an annual basis where the drive for an evidence based approach is paramount.

Professor Tarassenko has been the holder of the Chair in Electrical Engineering at Oxford University since October 1997. He was elected to a Fellowship of the Institute of Electrical Engineers (IEE) in 1996, when he was also awarded the IEE Mather Premium for his work on neural networks, and to a Fellowship of the Royal Academy of Engineering in 2000. He received a British Computer Society Medal in 1996 for his work on neural network analysis of sleep disorders. His work on mobile phones for healthcare was awarded the E-health 2005 Innovation Award for "best device to empower patients". He was awarded the 2006 Silver Medal of the Royal Academy of Engineering and he also won the Institute of Engineering & Technology IT Award for "Data Fusion Software for Early Detection of Patient Deterioration", also in 2006.
Professor Tarassenko is the author of 140 refereed publications, 150 conference papers, 3 books and 24 patents. He was a founder director of Oxford BioSignals Ltd in May 2000 and a founder director of e-San Ltd (now t+ Medical) in February 2002. He is a member of the Wellcome Trust Technology Transfer Strategy Panel. He is the Bioengineering theme leader for the joint NHS/University Oxford Biomedical Research Centre (2007-2012), the Director of the Oxford Institute of Biomedical Engineering since October 2008, and the Director of the Centre of Excellence in Medical Engineering jointly funded by the Wellcome Trust and EPSRC since October 2009.

Hywel directs the Centre of Evidence-Based Dermatology at the University of Nottingham, which contains the Cochrane Skin Group, the UK Dermatology Clinical Trials Network and the national electronic library for skin diseases. He trained in dermatology at King’s College Hospital and St. John’s dermatology Centre in London before taking up his current position in Nottingham. Hywel is national lead for the Comprehensive Clinical Research Network dermatology speciality group and he has a particular interest in evidence-based medicine and clinical trials. His main disease interests include childhood eczema, non-melanoma skin cancer and acne. Hywel is also an NIHR Senior Investigator and has recently been appointed as Chair of the NIHR Health Technology Assessment Commissioning Board and deputy director of the HTA Programme.

Dr. Gavin Yamey leads the San Francisco hub of E2Pi, the Evidence to Policy initiative, at University of California San Francisco. He is a former Assistant Editor at the BMJ, and Senior Editor at PLoS Medicine, and was the Principal Investigator for a $1.1m grant from the Bill & Melinda Gates Foundation to launch PLoS Neglected Tropical Diseases, the worldís first journal devoted to tropical diseases of poverty. In 2009, he was awarded a Kaiser Family Foundation Mini-Fellowship in Global Health Reporting. He has published over 100 articles in peer-reviewed medical journals, with a focus on global health ethics, policy, and governance, malaria, HIV, and neglected tropical diseases. His new book, The Handbook of Global Health Policy, co-edited with Garrett Brown at the University of Sheffield, will be published by Wiley-Blackwell in 2012. He has been an adviser to the World Health Organization and the UNICEF/UNDP/WHO/World Bank Special Programme for Research and Training in Tropical Diseases. Dr. Yamey has training in clinical medicine (from the University of Oxford and University College London), medical journalism (he was an editorial registrar at the BMJ), and public health (from the London School of Hygiene and Tropical Medicine).





